Dr. Arnaud Rosier, the co-founder of the health tech company Implicity, provides a window into how artificial intelligence impacts his field.
  1. Hi, please tell us about your journey in AI technology and how you started with Implicity.

I founded Implicity about six years ago to solve some of the workflow challenges I faced as a Cardiac Electrophysiologist. My Ph.D. is in health informatics, and I wanted to develop a tool that would enable the adoption of remote cardiac patient monitoring. So, we developed a cloud-based platform leveraging machine learning and AI-based algorithms to aggregate data from various cardiac implantable electronic devices (CIEDs) and manage the entire clinical and administrative workflow. This allows cardiologists, electrophysiologists, and their teams to scale remote patient care and optimize revenues.

Today, Implicity covers more than 70,000 patients in 100 medical facilities across the United States and Europe. In addition, the platform is used by clinical and academic researchers. Investigators can use intelligent cardiac remote care and research solution to support their studies.

Read the full interview by AiThority – AI Technology Insights